OOIR: Observatory of International Research

Papers

(The H4-Index of Drug Delivery is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice	198
Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity	191
Advanced hydrogel material for colorectal cancer treatment	186
The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery	154
Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis	141
Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model	137
Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation	133
Immunomodulatory nano-preparations for rheumatoid arthritis	117
Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility	93
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment	89
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems	76
Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis	76
Recent progress in nanotechnology-based drug carriers for resveratrol delivery	70
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice	67
Alginate-based aerogels as wound dressings for efficient bacterial capture and enhanced antibacterial photodynamic therapy	64
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis	64
Thermo-sensitive self-assembly of poly(ethylene imine)/(phenylthio) acetic acid ion pair in surfactant solutions	58
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements	58
Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach	58
Development of a single-dose Q fever vaccine with an injectable nanoparticle-loaded hydrogel: effect of sustained co-delivery of antigen and adjuvant	57
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions	53
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats	53
Effect of pH-sensitive nanoparticles on inhibiting oral biofilms	52
The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics	51
Correction	50

Effect and mechanism of paclitaxel loaded on magnetic Fe ₃ O ₄ @mSiO ₂ -NH ₂	49
Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin	47
Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques	47
Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer	46
Nanoparticles-based anti-aging treatment of Alzheimer’s disease	46
Exploring the efficacy and constraints of platinum nanoparticles as adjuvant therapy in silicosis management	46
Advance in placenta drug delivery: concern for placenta-originated disease therapy	45
SREKA-targeted liposomes for highly metastatic breast cancer therapy	45
Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis	45
Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption	45
Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases	44
Platinum-based drugs and hydrogel: a promising anti-tumor combination	44
Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments	44
Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design: in-vitro characterization and in-vivo assessment	43
Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs	43
PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA	43
Application of chitosan-based drug delivery systems in the treatment of bacterial diseases: a review	43
Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective	42
PEGylation technology: addressing concerns, moving forward	42
Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease	42
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers	42